| 000 | 00959nam a2200277zi 4500 | ||
|---|---|---|---|
| 005 | 20230201161209.0 | ||
| 008 | 081104s2007 xxua 000 0 eng | ||
| 020 | _a1574444506 (papel alcalino) | ||
| 020 | _a9781574444506 (papel alcalino) | ||
| 035 | _aMX001001160597 | ||
| 040 |
_aDLC _bspa _cDLC _dBAKER _dUKM _dC#P _dBTCTA _dYDXCP _dDLC _dUNAMX |
||
| 050 | 0 |
_aR857.B5 _bB57 |
|
| 082 | 0 | 0 |
_a615/.19 _222 |
| 245 | 0 | 0 |
_aBiochips as pathways to drug discovery / _cedited by Andrew Carmen, Gary Hardiman |
| 300 |
_a386 páginas : _bhojas (algunas a color) |
||
| 490 | 0 |
_aDrug discovery series ; _v7 |
|
| 650 | 0 | _aBiochips | |
| 650 | 0 | _aDesarrollo de medicamentos | |
| 700 | 1 |
_aCarmen, Andrew, _eeditor |
|
| 700 | 1 |
_aHardiman, Gary, _d1966- , _eeditor |
|
| 264 | 1 |
_aBoca Raton, FL : _bCRC Press/Taylor & Francis, _cc2007 |
|
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 999 |
_c3235 _d3235 |
||